Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018

This statistic shows the compound annual growth rates of selected pharmaceutical major therapeutic classes in 2014-2018, based on spending. In that period, spending on autoimmune agents increased with a compound annual growth rate of 15.4 percent. For pain drugs, an increase of 0.9 percent annually was reported for the same period.

Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*

Compound annual growth rate
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2019



Survey time period

2014 to 2018

Supplementary notes

* This statistic includes 8 developed and 6 pharmerging countries: U.S., EU5, Japan, Canada, China, Brazil Russia, India, Turkey, Mexico. Values are compound annual growth rates (CAGRs).

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.